Journal of Materials Chemistry B
DOI: 10.1039/C3TB20957A
crystal properties. The xerogels of 1-4 contained non-spherulitic
and spherulitic fibers as their structural elements in the
micrometer range, in addition to other micro- and nanoscale
aggregates. There is a possibility that all or some of the observed
xerogel structural components may be found in the wet gels as
well, but further studies are needed to prove their composition.
Taking into account the importance of BPs in medicine and
pharmacy we believe that this innovation opens many new
opportunities for the use of BP derivatives in different
applications.
Acknowledgements
Chief Laboratory Technicians Maritta Salminkoski and Helena
Vepsäläinen (School of Pharmacy, University of Eastern
Finland), and students Maciek Duda and Agata Zerka (Wroclaw
University of Technology, Poland) are thanked for their help in
the synthetic and analytical work. Laboratory Engineer Esa
Haapaniemi (Department of Chemistry, University of Jyväskylä)
is acknowledged for his help in measuring the NMR spectra and
Laboratory Technician Hannu Salo (Department of Chemistry,
University of Jyväskylä) for SEM images. This work was
supported by the Academy of Finland (project no. 132070 for
A.A., project no. 218178 for E.S., and projects no. 119616 and
255648 for M.L.), strategic funding of UEF, and PhoSciNet
COST action.
Fig. 15 SEM micrographs of (a) xerogel of 1, (b) in situ-prepared material
of 1, (c) xerogel of 2, (d) in situ-prepared material of 2. The scale bars are
(a) 20 µm, (b) 100 µm, (c) 40 µm, (d) 100 µm.
The wet gels of 1-3 differed from the xerogels according to the
13C CPMAS-studies, but whether this affects the observable
morphology of the xerogels remains an open question. Although
the dimensions of the crystallites determined using PXRD data
could in principle be compared to those of the structures observed
in SEM micrographs, the structural objects found in SEM are
often composed of larger crystallite agglomerates, instead of “X-
ray visible” single crystallites, thereby indicating particle size
instead of crystallite size.48 The appearance of the xerogel of 3
could conform to the crystallite size range, but the xerogels of 1,
2, and 4 did not readily fit into the same category based on the
micrographs, probably because of the abovementioned reasons.
At any rate, the one-to-one correspondence between the observed
structures in SEM and the data obtained from XRD- or
spectroscopic techniques cannot be verified, since different
xerogel samples were used in them.45,46 Further studies would be
needed to establish such a connection.
References
1 M. de Loos, B.L. Feringa, J.H. van Esch, Eur. J. Org. Chem. 2005, 17,
3615.
2 N.A. Peppas, P. Bures, W. Leobandung, H. Ichikawa, Eur. J. Pharm.
Biopharm. 2000, 50, 27.
3 A.S. Hoffman, Adv. Drug Deliv. Rev. 2012, 64, 18.
4 L.A. Estroff, A.D. Hamilton, Chem. Rev. 2004, 104, 1201.
5 R.G.G. Russel, Bone 2011, 49, 2-19.
6 G. Morgan, A. Lipton, Semin. Oncol. 2010, 37, S30.
7 J. R. Green, Oncologist 2004, 9 (suppl 4), 3.
8 C.A. Rodrígues-Poveda, D. González-Pacanowska, S.H. Szajnman, J.B.
Rodríguez, Antimicrob. Agents Chemother. 2012, 56, 4483.
9 S. Ghosh, J.M.W. Chan, C.R. Lea, G.A. Meins, J.C. Lewis, Z.S.
Tovian, T.C. Flessner, I. Loftus, H. Bruchhaus, S.L. Kendrick, R.G.
Croft, S. Kemp, R.M. Kobayashi, T. Nozaki, E. Oldfield, J. Med.
Chem. 2004, 47, 175.
10 W.P. Maksymowych, Curr. Med. Chem. Anti Inflamm. Anti Allergy
Agents 2002, 1, 15.
11 D. Santini, M.E. Fratto, B. Vincenzi, A. La Cesa, C. Dianzani, G.
Tonini, BioDrugs 2004, 18, 269.
12 X. Yang, S. Akhtar, S. Rubino, K. Leifer, J. Hilborn, D. Ossipov,
Chem. Mater. 2012, 24, 1690.
13 E.A. Rayment, T.R. Dargaville, G.K. Shooter, G.A. George, Z. Upton,
Biomaterials 2008, 29, 1785.
14 K. Xu, W. Ge, G. Liang, L. Wang, Z. Yang, Q. Wang, I-M. Hsing, B.
Xu, Int. J Radiat. Biol. 2008, 85, 353.
15 S. Girard, F. Paqué, M. Badertscher, B. Sener, M. Zehnder, Int. Endod.
J. 2005, 38, 810.
16 G.T. Reddy, T.M.P. Kumar, Drug Deliv. 2005, 12, 217.
17 A. Sharma, A.R. Pradeep, J. Periodontol. 2012, 83, 19.
18 S. Ponader, H. Brandt, E. Vairaktaris, C. von Wilmowsky, E. Nkenke,
K.A. Schlegel, F.W. Neukama, S. Holst, F.A. Müller, P. Greil,
Colloids Surf. B Biointerfaces 2008, 64, 275.
19 M. George, G. P. Funkhouser, R. G. Weiss, Langmuir 2008, 24, 3537.
20 M. George, G.P. Funkhouser, P. Terech, R.G. Weiss, Langmuir 2006,
22, 7885.
Conclusions
In this article we report, for the first time, the gelation properties
of bisphosphonate derivatives. Three of the four BP derivatives
synthesized (1-3) were proven to act as hydrogelators, whereas
one of the compounds (4) showed organogelating properties. The
chemical and physical nature of the formed gels were
investigated with a wide selection of analytical tools, including
liquid and solid state NMR as well as IR spectroscopy, scanning
electron microscopy, powder X-ray diffraction, and thermal
analysis. A detailed picture of the solid state structures of the
synthesis products as well as the corresponding xerogels were
drawn together with the thermal degradation and hydration levels
of the compounds. Based on the obtained results, water plays an
important role in the hydrogels formed by compounds 1-3. The
role of the water seems to be different in the case of compound 2
with 12 carbon atoms in the alkyl chain compared to that of
compounds 1 and 3 with 11 and 13 carbon atoms in the alkyl
chain, respectively. The long alkyl chains combined with the
ability of the phosphonic acid end groups to form hydrogen bonds
most likely guide the structures to form parallel-packed structure
modifications, contributing to high crystallinity of compounds 1-
3 and their xerogels, which moreover showed potential liquid
21 N. Margiotta, R. Ostuni, D. Teoli, M. Morpurgo, N. Realdon, B.
Palazzo, G. Natile, Dalton Trans. 2007, 3131.